首页 > 最新文献

International Journal of Endocrinology and Metabolism最新文献

英文 中文
Effects of Vitamin D on Left Ventricular Ejection Fraction in Patients with Systolic Heart Failure: A Double-Blind Randomized Clinical Trial. 维生素D对收缩期心力衰竭患者左心室射血分数的影响:一项双盲随机临床试验
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-09-02 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.103528
Reza Hassanzadeh-Makoui, Maziar Jamei, Masoud Hassanzadeh-Makoui, Hamid Khederlou

Background: Heart failure is a pathophysiologic state in which the cardiac output is not able to supply the body with enough oxygen and nutrients. The prevalence of heart failure has increased dramatically over the last decades. Vitamin D levels in patients with chronic heart failure are lower than healthy controls, and vitamin D deficiency has a direct relationship with mortality.

Objectives: This study aimed to evaluate the effect of vitamin D on the improvement of left ventricular ejection fraction in patients with systolic heart failure.

Methods: In this case-control clinical trial, 142 patients with chronic systolic heart failure were identified. Based on the inclusion and exclusion criteria, 114 patients were enrolled in the study and randomly divided into two groups. One group (n = 58) received 50,000 units of vitamin D capsules weekly for eight weeks, and the patients in the other group (n = 56) received a placebo. After excluding 15 patients from the placebo group and 17 patients from the intervention group during the study, according to the exclusion criteria, 41 patients were evaluated in both groups for ejection fraction changes after two months.

Results: According to the results of this research, there were no statistically significant differences in the baseline parameters between the two studied groups. The intervention group consisted of 18 female and 23 male patients with a mean age of 61.68 ± 19.8 years. Moreover, the placebo group included 21 female and 20 male patients with a mean age of 62.12 ± 18.2 years. After a 2-month follow-up, the intervention group showed statistically significant changes in ejection fraction, end-diastolic volume, and heart failure class compared to the placebo group. Also, the serum level of albumin and vitamin D in the intervention group was significantly higher than the placebo group.

Conclusions: The results of this study show that vitamin D treatment can improve the ejection fraction and functional ability of patients with vitamin D deficiency. If more comprehensive studies support this hypothesis, vitamin D deficiency assessment and correction in patients with chronic heart failure may be recommended.

背景:心力衰竭是心输出量不能为机体提供足够的氧气和营养的一种病理生理状态。在过去的几十年里,心力衰竭的发病率急剧上升。慢性心力衰竭患者的维生素D水平低于健康对照组,维生素D缺乏与死亡率有直接关系。目的:本研究旨在评价维生素D对改善收缩期心力衰竭患者左心室射血分数的作用。方法:对142例慢性收缩期心力衰竭患者进行病例对照临床研究。根据纳入和排除标准,114例患者入组,随机分为两组。一组(n = 58)连续八周每周服用50,000单位维生素D胶囊,另一组(n = 56)服用安慰剂。在研究过程中,将安慰剂组15例患者和干预组17例患者排除后,根据排除标准,对两组41例患者在两个月后的射血分数变化进行评估。结果:本研究结果显示,两组患者基线参数差异无统计学意义。干预组患者女性18例,男性23例,平均年龄61.68±19.8岁。此外,安慰剂组包括21名女性和20名男性患者,平均年龄为62.12±18.2岁。经过2个月的随访,与安慰剂组相比,干预组在射血分数、舒张末期容积和心力衰竭等级上有统计学意义的变化。此外,干预组的血清白蛋白和维生素D水平显著高于安慰剂组。结论:本研究结果表明,维生素D治疗可改善维生素D缺乏症患者的射血分数和功能能力。如果更全面的研究支持这一假设,慢性心力衰竭患者的维生素D缺乏评估和纠正可能会被推荐。
{"title":"Effects of Vitamin D on Left Ventricular Ejection Fraction in Patients with Systolic Heart Failure: A Double-Blind Randomized Clinical Trial.","authors":"Reza Hassanzadeh-Makoui,&nbsp;Maziar Jamei,&nbsp;Masoud Hassanzadeh-Makoui,&nbsp;Hamid Khederlou","doi":"10.5812/ijem.103528","DOIUrl":"https://doi.org/10.5812/ijem.103528","url":null,"abstract":"<p><strong>Background: </strong>Heart failure is a pathophysiologic state in which the cardiac output is not able to supply the body with enough oxygen and nutrients. The prevalence of heart failure has increased dramatically over the last decades. Vitamin D levels in patients with chronic heart failure are lower than healthy controls, and vitamin D deficiency has a direct relationship with mortality.</p><p><strong>Objectives: </strong>This study aimed to evaluate the effect of vitamin D on the improvement of left ventricular ejection fraction in patients with systolic heart failure.</p><p><strong>Methods: </strong>In this case-control clinical trial, 142 patients with chronic systolic heart failure were identified. Based on the inclusion and exclusion criteria, 114 patients were enrolled in the study and randomly divided into two groups. One group (n = 58) received 50,000 units of vitamin D capsules weekly for eight weeks, and the patients in the other group (n = 56) received a placebo. After excluding 15 patients from the placebo group and 17 patients from the intervention group during the study, according to the exclusion criteria, 41 patients were evaluated in both groups for ejection fraction changes after two months.</p><p><strong>Results: </strong>According to the results of this research, there were no statistically significant differences in the baseline parameters between the two studied groups. The intervention group consisted of 18 female and 23 male patients with a mean age of 61.68 ± 19.8 years. Moreover, the placebo group included 21 female and 20 male patients with a mean age of 62.12 ± 18.2 years. After a 2-month follow-up, the intervention group showed statistically significant changes in ejection fraction, end-diastolic volume, and heart failure class compared to the placebo group. Also, the serum level of albumin and vitamin D in the intervention group was significantly higher than the placebo group.</p><p><strong>Conclusions: </strong>The results of this study show that vitamin D treatment can improve the ejection fraction and functional ability of patients with vitamin D deficiency. If more comprehensive studies support this hypothesis, vitamin D deficiency assessment and correction in patients with chronic heart failure may be recommended.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e103528"},"PeriodicalIF":2.1,"publicationDate":"2020-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/b9/ijem-18-3-103528.PMC7695351.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38657223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Association of Evening Chronotype with Poor Control of Type 2 Diabetes: Roles of Sleep Duration and Insomnia Level. 夜间睡眠类型与2型糖尿病控制不良的关系:睡眠时间和失眠水平的作用
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-08-30 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.99701
Sima Hashemipour, Zohreh Yazdi, Niloofar Mahabad

Background: Evening chronotype is usually associated with insomnia and short sleep duration.

Objectives: To investigate the independent association of chronotype with diabetes control.

Methods: In this cross-sectional study, 140 patients with type 2 diabetes were studied. The insomnia score was examined by a 7-item questionnaire. Also, chronotype was assessed by a 19-item questionnaire, and using the questionnaire, the patients were divided into three groups of morning, intermediate, and evening. This questionnaire has been developed for evaluating the preference for performing mental and physical activities at a special time of day. The Multivariate hierarchical analysis was applied for investigating the independent association of chronotype and glycated hemoglobin (HbA1c).

Results: The fasting blood glucose and HbA1c levels were significantly different across all the three chronotype groups such that it had the highest value in the evening group and the lowest value in the morning group (FBS = 164.5 ± 34.1 mg/dL and HbA1c = 8.7% ± 1.7, in the evening group, and FBS = 132.7 ± 23.1 mg/dL and HbA1c = 6.9% ± 0.4 in the morning group, P < 0.001). The morning group had longer sleep duration and less insomnia than other groups. Results of the hierarchical regression analysis showed that the chronotype explained 28.4% of the variance of HbA1c. Results of the final model demonstrated that the chronotype had a relationship with HbA1c, independent of body mass index (BMI), time of going to bed, and insomnia score.

Conclusions: Evening chronotype is associated with poorer control of diabetes, independent of BMI and sleep variables.

背景:夜间睡眠类型通常与失眠和睡眠时间短有关。目的:探讨时间型与糖尿病控制的独立关系。方法:对140例2型糖尿病患者进行横断面研究。失眠得分通过一份包含7个项目的问卷来检验。同时,采用19项问卷对患者进行睡眠类型评估,并将患者分为早、中、晚三组。编制这份问卷是为了评估人们对在一天中的特定时间进行脑力和体力活动的偏好。采用多变量分层分析研究时间型与糖化血红蛋白(HbA1c)的独立相关性。结果:空腹血糖和HbA1c水平在3个时间类型组之间存在显著差异,夜间组最高,早晨组最低(FBS = 164.5±34.1 mg/dL, HbA1c = 8.7%±1.7,晚上组;FBS = 132.7±23.1 mg/dL, HbA1c = 6.9%±0.4,早晨组,P < 0.001)。与其他组相比,早起组的睡眠时间更长,失眠症更少。分层回归分析结果显示,时间型解释了28.4%的HbA1c方差。最终模型的结果表明,睡眠类型与HbA1c有关系,独立于体重指数(BMI)、睡觉时间和失眠评分。结论:夜间睡眠类型与糖尿病控制较差相关,独立于BMI和睡眠变量。
{"title":"Association of Evening Chronotype with Poor Control of Type 2 Diabetes: Roles of Sleep Duration and Insomnia Level.","authors":"Sima Hashemipour,&nbsp;Zohreh Yazdi,&nbsp;Niloofar Mahabad","doi":"10.5812/ijem.99701","DOIUrl":"https://doi.org/10.5812/ijem.99701","url":null,"abstract":"<p><strong>Background: </strong>Evening chronotype is usually associated with insomnia and short sleep duration.</p><p><strong>Objectives: </strong>To investigate the independent association of chronotype with diabetes control.</p><p><strong>Methods: </strong>In this cross-sectional study, 140 patients with type 2 diabetes were studied. The insomnia score was examined by a 7-item questionnaire. Also, chronotype was assessed by a 19-item questionnaire, and using the questionnaire, the patients were divided into three groups of morning, intermediate, and evening. This questionnaire has been developed for evaluating the preference for performing mental and physical activities at a special time of day. The Multivariate hierarchical analysis was applied for investigating the independent association of chronotype and glycated hemoglobin (HbA1c).</p><p><strong>Results: </strong>The fasting blood glucose and HbA1c levels were significantly different across all the three chronotype groups such that it had the highest value in the evening group and the lowest value in the morning group (FBS = 164.5 ± 34.1 mg/dL and HbA1c = 8.7% ± 1.7, in the evening group, and FBS = 132.7 ± 23.1 mg/dL and HbA1c = 6.9% ± 0.4 in the morning group, P < 0.001). The morning group had longer sleep duration and less insomnia than other groups. Results of the hierarchical regression analysis showed that the chronotype explained 28.4% of the variance of HbA1c. Results of the final model demonstrated that the chronotype had a relationship with HbA1c, independent of body mass index (BMI), time of going to bed, and insomnia score.</p><p><strong>Conclusions: </strong>Evening chronotype is associated with poorer control of diabetes, independent of BMI and sleep variables.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e99701"},"PeriodicalIF":2.1,"publicationDate":"2020-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/de/ijem-18-3-99701.PMC7699824.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38678167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome? 维生素D和COVID-19:缺乏维生素D会导致不利的结果吗?
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-08-25 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.107669
Sameer Bhimani, Hiba Khalid, Momina Khalid, Rohan Kumar Ochani
{"title":"Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?","authors":"Sameer Bhimani,&nbsp;Hiba Khalid,&nbsp;Momina Khalid,&nbsp;Rohan Kumar Ochani","doi":"10.5812/ijem.107669","DOIUrl":"https://doi.org/10.5812/ijem.107669","url":null,"abstract":"<jats:p />","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e107669"},"PeriodicalIF":2.1,"publicationDate":"2020-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/54/ijem-18-3-107669.PMC7695224.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38657224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Maternal Dietary Components During Pregnancy and/or Lactation with Insulin-Dependent Diabetes Mellitus. 孕期和/或哺乳期孕妇饮食成分与胰岛素依赖型糖尿病的关系
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-07-22 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.93076
Shadi Salek, Mahin Hashemipour, Awat Feizi, Silva Hovsepian, Roya Kelishadi

Context: Considering the increasing trend in the incidence of type 1 diabetes mellitus (T1DM), the identification of its environmental determinants, especially those related to the prenatal and lactation period, might ultimately result in primary prevention of the disease. We aimed to review the evidence of the association between mothers' dietary components during pregnancy and/or lactation with T1DM.

Evidence acquisition: An electronic and comprehensive literature search was performed until August 2019 in the international databases, including Web of Science (ISI), PubMed, and Scopus, using the following keywords: type 1 diabetes mellitus, autoimmunity, mother, maternal, diet and lactation in different combinations. Papers related to the objectives of the study were selected.

Results: Based on our review, the maternal consumption of meat, especially processed meat, was associated with increased risk of T1DM, whereas the maternal use of vegetables, potato, low-fat margarine, and berries showed protective effects against the development of T1DM in offspring. There was no significant association between the use of multivitamins and mineral supplements with T1DM, according to the available data. The results of the reviewed studies regarding the association between the maternal use of vitamin D, fatty acids, and coffee during pregnancy with T1DM were not consistent and conclusive.

Conclusions: Findings of this review indicate that the maternal consumption of some foods is associated with increased or decreased risk of T1DM. However, for some foods or dietary components, including coffee, vitamin D, and fatty acids, the results are not conclusive. We conclude that although maternal diet could influence the development of insulin autoantibodies (IA) and T1DM in offspring, there is no sufficient evidence for most nutrients, and available data are controversial, which should be dealt with in future cohort or interventional studies.

背景:考虑到1型糖尿病(T1DM)发病率的上升趋势,确定其环境决定因素,特别是与产前和哺乳期有关的环境决定因素,可能最终导致该疾病的一级预防。我们的目的是回顾孕期和/或哺乳期母亲饮食成分与T1DM之间关系的证据。证据获取:截至2019年8月,在包括Web of Science (ISI)、PubMed和Scopus在内的国际数据库中进行了电子和全面的文献检索,使用以下关键词:1型糖尿病、自身免疫、母亲、母体、不同组合的饮食和哺乳。选择与研究目标相关的论文。结果:根据我们的综述,母亲食用肉类,特别是加工肉类,与T1DM的风险增加有关,而母亲食用蔬菜、土豆、低脂人造黄油和浆果对后代T1DM的发展有保护作用。根据现有的数据,复合维生素和矿物质补充剂的使用与T1DM之间没有显著的联系。关于孕妇在妊娠期间服用维生素D、脂肪酸和咖啡与T1DM之间关系的研究结果并不一致,也没有结论性。结论:本综述的发现表明,母亲食用某些食物与T1DM风险的增加或降低有关。然而,对于一些食物或饮食成分,包括咖啡、维生素D和脂肪酸,结果并不确定。我们的结论是,尽管母亲的饮食可能会影响后代胰岛素自身抗体(IA)和T1DM的发展,但大多数营养物质没有足够的证据,现有的数据是有争议的,这应该在未来的队列或干预研究中进行处理。
{"title":"Association of Maternal Dietary Components During Pregnancy and/or Lactation with Insulin-Dependent Diabetes Mellitus.","authors":"Shadi Salek,&nbsp;Mahin Hashemipour,&nbsp;Awat Feizi,&nbsp;Silva Hovsepian,&nbsp;Roya Kelishadi","doi":"10.5812/ijem.93076","DOIUrl":"https://doi.org/10.5812/ijem.93076","url":null,"abstract":"<p><strong>Context: </strong>Considering the increasing trend in the incidence of type 1 diabetes mellitus (T1DM), the identification of its environmental determinants, especially those related to the prenatal and lactation period, might ultimately result in primary prevention of the disease. We aimed to review the evidence of the association between mothers' dietary components during pregnancy and/or lactation with T1DM.</p><p><strong>Evidence acquisition: </strong>An electronic and comprehensive literature search was performed until August 2019 in the international databases, including Web of Science (ISI), PubMed, and Scopus, using the following keywords: type 1 diabetes mellitus, autoimmunity, mother, maternal, diet and lactation in different combinations. Papers related to the objectives of the study were selected.</p><p><strong>Results: </strong>Based on our review, the maternal consumption of meat, especially processed meat, was associated with increased risk of T1DM, whereas the maternal use of vegetables, potato, low-fat margarine, and berries showed protective effects against the development of T1DM in offspring. There was no significant association between the use of multivitamins and mineral supplements with T1DM, according to the available data. The results of the reviewed studies regarding the association between the maternal use of vitamin D, fatty acids, and coffee during pregnancy with T1DM were not consistent and conclusive.</p><p><strong>Conclusions: </strong>Findings of this review indicate that the maternal consumption of some foods is associated with increased or decreased risk of T1DM. However, for some foods or dietary components, including coffee, vitamin D, and fatty acids, the results are not conclusive. We conclude that although maternal diet could influence the development of insulin autoantibodies (IA) and T1DM in offspring, there is no sufficient evidence for most nutrients, and available data are controversial, which should be dealt with in future cohort or interventional studies.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e93076"},"PeriodicalIF":2.1,"publicationDate":"2020-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/dc/ijem-18-3-93076.PMC7695223.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38659817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. 补充维生素D对非酒精性脂肪性肝病患者的影响:一项系统综述和荟萃分析
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-07-07 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.97205
Yali Wei, Shuli Wang, Yan Meng, Qingtao Yu, Qian Wang, Hongzhao Xu, Huacai Yuan, Xiaoxu Li, Liyong Chen

Context: Vitamin D (VD) has been found to play a key role in nonalcoholic fatty liver disease (NAFLD). This meta-analysis explored the effects of VD supplementation in patients with NAFLD.

Methods: The PubMed, EMBASE, and the Cochrane Library databases were searched to find randomized control trials (RCTs) that measured the changes between the VD supplement group and the control group until May 2019. Standard mean difference (SMD) with 95% confidence intervals (CI) was calculated when data units were different, otherwise weighted mean difference (WMD) and 95% CI was calculated. Heterogeneity was assessed using the I2 statistic.

Results: Eight RCTs with 624 individuals were extracted. The main indicators, including serum alanine aminotransferase (WMD = -0.052; 95% CI: -3.740, 3.636; P = 0.978) and aspartate aminotransferase concentrations (WMD = -0.479; 95% CI: -2.791, 1.833; P = 0.685) were not significantly different between the intervention and placebo groups. In addition, no significant intergroup difference was observed in the following secondary indicators: fasting blood glucose (WMD = 0.466; 95% CI: -5.313, -10.879; P = 0.061), homeostasis model assessment (WMD = 0.380, 95% CI: -0.162, 0.923; P = 0.169), serum insulin concentration (WMD = 0.760; 95% CI: -0.532, 2.052; P = 0.249), high-density lipoprotein (WMD = -0.012; 95% CI: -0.188, 0.164; P = 0.891), and low-density lipoprotein (WMD = -0.115; 95% CI: -3.849, -3.620; P = 0.952).

Conclusions: The results indicate that VD supplementation does not improve liver enzymes, insulin resistance, glucose metabolism parameters, and lipid levels in patients with NAFLD.

背景:维生素D (VD)已被发现在非酒精性脂肪性肝病(NAFLD)中起关键作用。本荟萃分析探讨了补充VD对NAFLD患者的影响。方法:检索PubMed、EMBASE和Cochrane Library数据库,寻找随机对照试验(rct),这些试验测量了VD补充剂组与对照组之间的变化,直至2019年5月。当数据单元不同时,计算标准平均差(SMD)和95%置信区间(CI),否则计算加权平均差(WMD)和95% CI。采用I2统计量评估异质性。结果:共提取8项随机对照试验,共624例。主要指标:血清丙氨酸转氨酶(WMD = -0.052;95% ci: -3.740, 3.636;P = 0.978)和天冬氨酸转氨酶浓度(WMD = -0.479;95% ci: -2.791, 1.833;P = 0.685),干预组与安慰剂组间无显著差异。此外,以下次要指标组间差异无统计学意义:空腹血糖(WMD = 0.466;95% ci: -5.313, -10.879;P = 0.061)、稳态模型评估(WMD = 0.380, 95% CI: -0.162, 0.923;P = 0.169),血清胰岛素浓度(WMD = 0.760;95% ci: -0.532, 2.052;P = 0.249),高密度脂蛋白(WMD = -0.012;95% ci: -0.188, 0.164;P = 0.891),低密度脂蛋白(WMD = -0.115;95% ci: -3.849, -3.620;P = 0.952)。结论:结果表明,VD补充不能改善NAFLD患者的肝酶、胰岛素抵抗、糖代谢参数和脂质水平。
{"title":"Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.","authors":"Yali Wei,&nbsp;Shuli Wang,&nbsp;Yan Meng,&nbsp;Qingtao Yu,&nbsp;Qian Wang,&nbsp;Hongzhao Xu,&nbsp;Huacai Yuan,&nbsp;Xiaoxu Li,&nbsp;Liyong Chen","doi":"10.5812/ijem.97205","DOIUrl":"https://doi.org/10.5812/ijem.97205","url":null,"abstract":"<p><strong>Context: </strong>Vitamin D (VD) has been found to play a key role in nonalcoholic fatty liver disease (NAFLD). This meta-analysis explored the effects of VD supplementation in patients with NAFLD.</p><p><strong>Methods: </strong>The PubMed, EMBASE, and the Cochrane Library databases were searched to find randomized control trials (RCTs) that measured the changes between the VD supplement group and the control group until May 2019. Standard mean difference (SMD) with 95% confidence intervals (CI) was calculated when data units were different, otherwise weighted mean difference (WMD) and 95% CI was calculated. Heterogeneity was assessed using the I2 statistic.</p><p><strong>Results: </strong>Eight RCTs with 624 individuals were extracted. The main indicators, including serum alanine aminotransferase (WMD = -0.052; 95% CI: -3.740, 3.636; P = 0.978) and aspartate aminotransferase concentrations (WMD = -0.479; 95% CI: -2.791, 1.833; P = 0.685) were not significantly different between the intervention and placebo groups. In addition, no significant intergroup difference was observed in the following secondary indicators: fasting blood glucose (WMD = 0.466; 95% CI: -5.313, -10.879; P = 0.061), homeostasis model assessment (WMD = 0.380, 95% CI: -0.162, 0.923; P = 0.169), serum insulin concentration (WMD = 0.760; 95% CI: -0.532, 2.052; P = 0.249), high-density lipoprotein (WMD = -0.012; 95% CI: -0.188, 0.164; P = 0.891), and low-density lipoprotein (WMD = -0.115; 95% CI: -3.849, -3.620; P = 0.952).</p><p><strong>Conclusions: </strong>The results indicate that VD supplementation does not improve liver enzymes, insulin resistance, glucose metabolism parameters, and lipid levels in patients with NAFLD.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e97205"},"PeriodicalIF":2.1,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/1c/ijem-18-3-97205.PMC7695226.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38659818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
A New Perspective in the Management of Graves’ Hyperthyroidism Graves甲状腺功能亢进症治疗的新视角
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-06-30 DOI: 10.5812/ijem.102270
F. Azizi
{"title":"A New Perspective in the Management of Graves’ Hyperthyroidism","authors":"F. Azizi","doi":"10.5812/ijem.102270","DOIUrl":"https://doi.org/10.5812/ijem.102270","url":null,"abstract":"<jats:p />","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49246609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review 抗甲状腺药物停药后复发的预测:一个叙述性的回顾
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-06-29 DOI: 10.5812/ijem.102346
Pei-Wen Wang
Context: Antithyroid drugs (ATD) are the first-line treatment for Graves’ disease (GD); however, relapse following treatment is approximately 30% - 40% in the first year, and 50% - 60% in the long term. Identification of risk factors that predict relapse, after discontinuing ATD, plays an important role in guiding therapeutic options. Evidence Acquisition: PubMed was used to search for studies published in English between 1995 and 2019. The following search terms were used: Graves’ disease, antithyroid drugs, relapse, recurrence, and outcome. The reference lists from review articles were also included in the search in order to find older journals. Results: Factors associated with a high recurrence rate, as reported in most studies, were divided into phenotype and genotype predictors. Phenotype factors included large goiter size, persistence of high TSH receptor antibody (TRAb), severe hyperthyroidism, smoking, younger age, male sex, and prior history of recurrence. Genotype factors included human leukocyte antigen (HLA), CD40, CTLA-4, PTPN22, Tg, and TSHR genes. In a subgroup analysis by age, genetic factors were better predictors in the younger group, while clinical signs were more useful in the older group. The reliability of using individual baseline risk factors to predict subsequent relapse is poor; however, predictive scores calculated by grouping single risk factors might help to predict future outcomes. Conclusions: Longer normalization time of TRAb, the persistence of a palpable goiter, and harboring genetic risk factors in younger patients are associated with high recurrence rate of GD. Multi-marker prediction models have been proposed and validated to improve the predictive value of relapse after ATD withdrawal.
背景:抗甲状腺药物(ATD)是Graves病(GD)的一线治疗药物;然而,治疗后的复发率在第一年约为30%-40%,在长期约为50%-60%。在停用ATD后,识别预测复发的风险因素在指导治疗选择方面发挥着重要作用。证据获取:PubMed用于搜索1995年至2019年间以英语发表的研究。使用了以下搜索术语:Graves病、抗甲状腺药物、复发、复发和结果。评论文章的参考文献列表也被包括在搜索中,以查找较旧的期刊。结果:如大多数研究所报道的,与高复发率相关的因素分为表型和基因型预测因素。表型因素包括甲状腺肿大、TSH受体抗体(TRAb)持续高、严重甲状腺功能亢进、吸烟、年龄较小、男性和既往复发史。基因型因素包括人类白细胞抗原(HLA)、CD40、CTLA-4、PTPN22、Tg和TSHR基因。在按年龄进行的亚组分析中,遗传因素在年轻组中是更好的预测因素,而临床体征在老年组中更有用。使用个体基线风险因素预测后续复发的可靠性较差;然而,通过对单个风险因素进行分组计算的预测得分可能有助于预测未来的结果。结论:TRAb正常化时间较长、可触及甲状腺肿持续存在以及年轻患者携带遗传危险因素与GD的高复发率有关。已经提出并验证了多标记预测模型,以提高ATD停药后复发的预测价值。
{"title":"Prediction of Relapse After Antithyroid Drugs Withdrawal: A Narrative Review","authors":"Pei-Wen Wang","doi":"10.5812/ijem.102346","DOIUrl":"https://doi.org/10.5812/ijem.102346","url":null,"abstract":"Context: Antithyroid drugs (ATD) are the first-line treatment for Graves’ disease (GD); however, relapse following treatment is approximately 30% - 40% in the first year, and 50% - 60% in the long term. Identification of risk factors that predict relapse, after discontinuing ATD, plays an important role in guiding therapeutic options. Evidence Acquisition: PubMed was used to search for studies published in English between 1995 and 2019. The following search terms were used: Graves’ disease, antithyroid drugs, relapse, recurrence, and outcome. The reference lists from review articles were also included in the search in order to find older journals. Results: Factors associated with a high recurrence rate, as reported in most studies, were divided into phenotype and genotype predictors. Phenotype factors included large goiter size, persistence of high TSH receptor antibody (TRAb), severe hyperthyroidism, smoking, younger age, male sex, and prior history of recurrence. Genotype factors included human leukocyte antigen (HLA), CD40, CTLA-4, PTPN22, Tg, and TSHR genes. In a subgroup analysis by age, genetic factors were better predictors in the younger group, while clinical signs were more useful in the older group. The reliability of using individual baseline risk factors to predict subsequent relapse is poor; however, predictive scores calculated by grouping single risk factors might help to predict future outcomes. Conclusions: Longer normalization time of TRAb, the persistence of a palpable goiter, and harboring genetic risk factors in younger patients are associated with high recurrence rate of GD. Multi-marker prediction models have been proposed and validated to improve the predictive value of relapse after ATD withdrawal.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2020-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42333389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Long-Term Antithyroid Treatment in Pediatric and Juvenile Graves’ Disease 儿童和青少年Graves病的长期抗甲状腺治疗
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-06-27 DOI: 10.5812/ijem.106491
H. Delshad, M. Takyar
Context: Thyroid hormones can affect the development and function of the central nervous system and various other organs. As such, the pathologic excess of these hormones, known as thyrotoxicosis, can be the source of significant damage during childhood and adolescence. The objective of this study was to review the management of Graves’ disease (GD) in the pediatric age group, especially concerning long-term antithyroid drug (ATD) treatment. Evidence Acquisition: A thorough search of literature published from 1980 to 2019 was performed in PubMed only for English language literature. The following key terms were used: “Graves’ disease, hyperthyroidism, thyrotoxicosis in children, thyrotoxicosis remission, thyrotoxicosis relapse, definite therapy, radioactive iodine, thyroidectomy, anti-thyroid drugs, propylthiouracil, methimazole, and carbimazole”. We also did a thorough search in review articles, observational studies, open-label/controlled randomized/non-randomized trials, and meta-analyses, as well as the articles cited by textbooks, chapters, and review articles, which led us to locate older sources of information on the topic. Results: More than 90% of thyrotoxicosis in the pediatric age group is attributable to GD. A host of strategies, including ATDs, radioiodine therapy, and surgery, are employed to treat this entity. However, there is still significant controversy regarding the most optimal strategy. Current evidence suggests that ATDs are the best initial treatment in pediatric patients with GD. Although ATDs are widely used, the duration of their administration is controversial and varies significantly between protocols. A major problem is the high relapse rate (up to 70%), but extending the duration of such treatment could potentially bring the remission rate up to 88%. Indications for using radioactive iodine treatment include the lack of remission following years of receiving ATDs, poor compliance, and the emergence of a major side effect. In pediatric patients aged five-years-old or younger who suffer from very large goiter, severe ophthalmopathy, and persistent hyperthyroidism, as well as those with the lack of response to or showing adverse effects of ATDs, it is advisable to consider total or near-total thyroidectomy. Conclusions: Antithyroid drugs are the mainstay of treatment of juvenile GD, and long-term methimazole therapy increases the remission rate in pediatric GD.
背景:甲状腺激素会影响中枢神经系统和其他各种器官的发育和功能。因此,这些激素的病理性过量,即甲状腺毒症,可能是儿童和青少年时期严重损伤的来源。本研究的目的是回顾儿童年龄组Graves病(GD)的治疗,特别是长期抗甲状腺药物(ATD)治疗。证据获取:PubMed对1980年至2019年发表的文献进行了彻底搜索,仅针对英语文献。使用了以下关键术语:“Graves病、甲状腺功能亢进症、儿童甲状腺毒症、甲状腺毒症缓解、甲状腺毒病复发、明确治疗、放射性碘、甲状腺切除术、抗甲状腺药物、丙基硫氧嘧啶、甲氧咪唑和卡比唑”。我们还对综述文章、观察性研究、开放标签/对照随机/非随机试验和荟萃分析,以及教科书、章节和综述文章引用的文章进行了彻底搜索,这使我们找到了该主题的旧信息来源。结果:在儿童年龄组中,90%以上的甲状腺毒症可归因于GD。采用了一系列策略,包括ATD、放射性碘治疗和手术来治疗这种疾病。然而,关于最优策略仍然存在重大争议。目前的证据表明,ATD是小儿GD患者的最佳初始治疗方法。尽管ATD被广泛使用,但其给药时间存在争议,并且不同方案之间差异很大。一个主要问题是复发率高(高达70%),但延长此类治疗的持续时间可能会使病情缓解率高达88%。使用放射性碘治疗的适应症包括接受ATD数年后没有缓解、依从性差以及出现主要副作用。对于患有巨大甲状腺肿、严重眼病和持续性甲状腺功能亢进的五岁或五岁以下的儿童患者,以及对ATDs缺乏反应或表现出不良反应的患者,建议考虑全甲状腺或近全甲状腺切除术。结论:抗甲状腺药物是治疗青少年GD的主要药物,长期甲巯咪唑治疗可提高儿童GD的缓解率。
{"title":"Long-Term Antithyroid Treatment in Pediatric and Juvenile Graves’ Disease","authors":"H. Delshad, M. Takyar","doi":"10.5812/ijem.106491","DOIUrl":"https://doi.org/10.5812/ijem.106491","url":null,"abstract":"Context: Thyroid hormones can affect the development and function of the central nervous system and various other organs. As such, the pathologic excess of these hormones, known as thyrotoxicosis, can be the source of significant damage during childhood and adolescence. The objective of this study was to review the management of Graves’ disease (GD) in the pediatric age group, especially concerning long-term antithyroid drug (ATD) treatment. Evidence Acquisition: A thorough search of literature published from 1980 to 2019 was performed in PubMed only for English language literature. The following key terms were used: “Graves’ disease, hyperthyroidism, thyrotoxicosis in children, thyrotoxicosis remission, thyrotoxicosis relapse, definite therapy, radioactive iodine, thyroidectomy, anti-thyroid drugs, propylthiouracil, methimazole, and carbimazole”. We also did a thorough search in review articles, observational studies, open-label/controlled randomized/non-randomized trials, and meta-analyses, as well as the articles cited by textbooks, chapters, and review articles, which led us to locate older sources of information on the topic. Results: More than 90% of thyrotoxicosis in the pediatric age group is attributable to GD. A host of strategies, including ATDs, radioiodine therapy, and surgery, are employed to treat this entity. However, there is still significant controversy regarding the most optimal strategy. Current evidence suggests that ATDs are the best initial treatment in pediatric patients with GD. Although ATDs are widely used, the duration of their administration is controversial and varies significantly between protocols. A major problem is the high relapse rate (up to 70%), but extending the duration of such treatment could potentially bring the remission rate up to 88%. Indications for using radioactive iodine treatment include the lack of remission following years of receiving ATDs, poor compliance, and the emergence of a major side effect. In pediatric patients aged five-years-old or younger who suffer from very large goiter, severe ophthalmopathy, and persistent hyperthyroidism, as well as those with the lack of response to or showing adverse effects of ATDs, it is advisable to consider total or near-total thyroidectomy. Conclusions: Antithyroid drugs are the mainstay of treatment of juvenile GD, and long-term methimazole therapy increases the remission rate in pediatric GD.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2020-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42397142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Glycemic Index (GI) Values for Major Sources of Dietary Carbohydrates in Iran. 伊朗饮食中碳水化合物主要来源的血糖指数(GI)值。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-06-27 eCollection Date: 2020-07-01 DOI: 10.5812/ijem.99793
Fatemeh Kazemi, Goodarz Danaei, Farshad Farzadfar, Vasanti Malik, Mahboubeh Parsaeian, Hamed Pouraram, Negar Zamaninour, Jamal Rahmani, Ahmad Reza Dorosty Motlagh

Background: The glycemic index (GI) values of staple foods are not available in a standardized method in Iran.

Objectives: The aim of this study was to measure the GI values of the major carbohydrate sources in a typical Iranian diet.

Methods: Using the international standard method, the GI values were determined for four wheat flatbreads, barley and rye bread, white and brown rice, as well as white and brown rice mixed with lentils. Twelve healthy adults were given 50 g anhydrous glucose three times (as the reference carbohydrate) and the test foods once each throughout the study. Using finger-prick blood samples, capillary blood glucose was measured using a reliable glucometer. The GI was calculated using the trapezoidal method.

Results: The GI values of the following types of bread were: Barley 66, Lavash 72, Taftoon 79, Sangak 82, rye 84, and Barbari 99. The GI values for brown and white rice were 65 and 71, respectively. The mixture of brown rice with lentils had a GI value of 55, and the mixture of white rice with lentils had a GI of 79.

Conclusions: The most common types of bread and white rice consumed in Iran have high GI values. There is potential to reduce the overall GI values in the Iranian diet by encouraging the consumption of barley bread and brown rice.

背景:主食的血糖指数(GI)值在伊朗没有标准化的方法。目的:本研究的目的是测量典型伊朗饮食中主要碳水化合物来源的GI值。方法:采用国际标准方法测定4种小麦面饼、大麦和黑麦面包、白米和糙米以及白米和糙米混合扁豆的GI值。在整个研究过程中,12名健康成年人被分三次给予50克无水葡萄糖(作为参考碳水化合物)和每次一次的测试食物。使用手指刺血样本,用可靠的血糖仪测量毛细血管血糖。采用梯形法计算GI。结果:大麦面包的GI值为66,Lavash 72, Taftoon 79, Sangak 82,黑麦84,Barbari 99。糙米和白米的GI值分别为65和71。糙米配小扁豆的GI值为55,白米配小扁豆的GI值为79。结论:伊朗最常见的面包和白米具有高GI值。通过鼓励食用大麦面包和糙米,有可能降低伊朗饮食中的总体GI值。
{"title":"Glycemic Index (GI) Values for Major Sources of Dietary Carbohydrates in Iran.","authors":"Fatemeh Kazemi,&nbsp;Goodarz Danaei,&nbsp;Farshad Farzadfar,&nbsp;Vasanti Malik,&nbsp;Mahboubeh Parsaeian,&nbsp;Hamed Pouraram,&nbsp;Negar Zamaninour,&nbsp;Jamal Rahmani,&nbsp;Ahmad Reza Dorosty Motlagh","doi":"10.5812/ijem.99793","DOIUrl":"https://doi.org/10.5812/ijem.99793","url":null,"abstract":"<p><strong>Background: </strong>The glycemic index (GI) values of staple foods are not available in a standardized method in Iran.</p><p><strong>Objectives: </strong>The aim of this study was to measure the GI values of the major carbohydrate sources in a typical Iranian diet.</p><p><strong>Methods: </strong>Using the international standard method, the GI values were determined for four wheat flatbreads, barley and rye bread, white and brown rice, as well as white and brown rice mixed with lentils. Twelve healthy adults were given 50 g anhydrous glucose three times (as the reference carbohydrate) and the test foods once each throughout the study. Using finger-prick blood samples, capillary blood glucose was measured using a reliable glucometer. The GI was calculated using the trapezoidal method.</p><p><strong>Results: </strong>The GI values of the following types of bread were: Barley 66, Lavash 72, Taftoon 79, Sangak 82, rye 84, and Barbari 99. The GI values for brown and white rice were 65 and 71, respectively. The mixture of brown rice with lentils had a GI value of 55, and the mixture of white rice with lentils had a GI of 79.</p><p><strong>Conclusions: </strong>The most common types of bread and white rice consumed in Iran have high GI values. There is potential to reduce the overall GI values in the Iranian diet by encouraging the consumption of barley bread and brown rice.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"18 3","pages":"e99793"},"PeriodicalIF":2.1,"publicationDate":"2020-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/b6/ijem-18-3-99793.PMC7695225.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38657220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Management of Graves’ Hyperthyroidism: More Than a Century of Progression 格雷夫斯甲亢的治疗:一个多世纪的进展
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2020-06-27 DOI: 10.5812/ijem.103943
H. Abdi, A. Amouzegar
Context: There are three therapeutic modalities for the management of Graves’ disease (GD), including thyroid surgery, radioactive iodine (RAI), and antithyroid drugs (ATDs). We aimed to briefly review the history of these treatment strategies and their advantages and disadvantages. Evidence Acquisition: We searched PubMed for English language articles using pertinent search terms. Results: Each treatment modality for GD is accompanied by several advantages and disadvantages. Nowadays, ATDs are the most commonly prescribed therapy for GD worldwide. The lack of well-designed, large RCTs comparing three different treatments for hyperthyroidism concerning various short-term and long-term outcomes has led to remarkable uncertainty in the preference of each of these treatments, as is evident in relevant guidelines from different societies. Recently, the efficacy and safety of long-term use of ATDs have been documented. Conclusions: Pros and cons of each therapeutic modality for Graves’ hyperthyroidism should be taken into account during the physician-patient discussion to select the primary treatment. Considering recent data about the long-term efficacy and safety of ATDs, it seems that the appropriate selection of Graves’ patients for long-term ATD therapy can be a new avenue in the treatment and even cure of GD.
背景:Graves病(GD)有三种治疗方式,包括甲状腺手术、放射性碘(RAI)和抗甲状腺药物(ATDs)。我们旨在简要回顾这些治疗策略的历史及其优缺点。证据获取:我们使用相关搜索词在PubMed中搜索英语文章。结果:GD的各种治疗方式各有优缺点。如今,ATDs是全球范围内最常用的GD处方治疗方法。由于缺乏设计良好的大型随机对照试验,比较三种不同的治疗甲状腺机能亢进的短期和长期结果,导致每种治疗方法的偏好存在显著的不确定性,这在不同协会的相关指南中是显而易见的。最近,长期使用ATDs的有效性和安全性已得到证实。结论:在医患讨论时应综合考虑Graves甲亢各种治疗方式的利弊,选择首选治疗方案。考虑到最近关于ATD的长期疗效和安全性的数据,似乎适当选择Graves患者进行长期ATD治疗可能是治疗甚至治愈GD的新途径。
{"title":"Management of Graves’ Hyperthyroidism: More Than a Century of Progression","authors":"H. Abdi, A. Amouzegar","doi":"10.5812/ijem.103943","DOIUrl":"https://doi.org/10.5812/ijem.103943","url":null,"abstract":"Context: There are three therapeutic modalities for the management of Graves’ disease (GD), including thyroid surgery, radioactive iodine (RAI), and antithyroid drugs (ATDs). We aimed to briefly review the history of these treatment strategies and their advantages and disadvantages. Evidence Acquisition: We searched PubMed for English language articles using pertinent search terms. Results: Each treatment modality for GD is accompanied by several advantages and disadvantages. Nowadays, ATDs are the most commonly prescribed therapy for GD worldwide. The lack of well-designed, large RCTs comparing three different treatments for hyperthyroidism concerning various short-term and long-term outcomes has led to remarkable uncertainty in the preference of each of these treatments, as is evident in relevant guidelines from different societies. Recently, the efficacy and safety of long-term use of ATDs have been documented. Conclusions: Pros and cons of each therapeutic modality for Graves’ hyperthyroidism should be taken into account during the physician-patient discussion to select the primary treatment. Considering recent data about the long-term efficacy and safety of ATDs, it seems that the appropriate selection of Graves’ patients for long-term ATD therapy can be a new avenue in the treatment and even cure of GD.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"1 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2020-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71264821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
International Journal of Endocrinology and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1